SUBSCRIBE
SUBSCRIBE

Elucida Oncology

NEWS
Business
Top Life Sciences Startups to Watch in 2022
BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
January 4, 2022
 · 
19 min read
 · 
Heather McKenzie
Business
Allorion Debuts with $40 Million to Enhance and Discover Precision Targets
The precision medicine company is developing mutant selective and isoform-specific drugs in non-conventional ways for well-known targets in the oncology and autoimmune spaces.
November 24, 2021
 · 
2 min read
 · 
Heather McKenzie
Two Cancer Companies Close Series A Rounds Netting $144 Million
Cancer companies Delfi Diagnostics and Elucida Oncology announced Series A raises worth $144 million so far.
January 13, 2021
 · 
2 min read
 · 
Mark Zipkin
IN THE PRESS
Pharm Country
Elucida Oncology to Present at the Evercore ISI 2024 Emerging Biotech Conference
February 15, 2024
 · 
1 min read
Pharm Country
Elucida Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
 · 
1 min read
Drug Development
Elucida Oncology Presents Encouraging Clinical Data from Phase 1/2 Study of ELU001 in Solid Tumors Overexpressing Folate Receptor Alpha at ESMO Congress 2023
October 23, 2023
 · 
6 min read
Pharm Country
Elucida Oncology Announces Abstract Accepted for Poster Presentation at ESMO Congress 2023
September 11, 2023
 · 
2 min read
Business
Elucida Oncology Appoints Ramzi Benamar as Chief Financial Officer
August 24, 2023
 · 
2 min read
Drug Development
Elucida Oncology Announces First Patient Dosed with ELU001 in Expansion Cohort of its Phase 1/2 Clinical Trial
July 20, 2023
 · 
3 min read
Drug Development
Elucida Oncology Announces Positive Early Phase 1 Safety Data Along with Preclinical Data for the Treatment of Brain Metastases for ELU001, an Anti-Folate Receptor Alpha C’Dot Drug Conjugate
April 20, 2023
 · 
4 min read
Pharm Country
Elucida Oncology to Present New Clinical and Preclinical Data at the 2023 AACR Annual Meeting
April 11, 2023
 · 
2 min read
Pharm Country
Elucida Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 3, 2023
 · 
1 min read
Pharm Country
Elucida Oncology to Present at the Piper Sandler 34th Annual Healthcare Conference
November 3, 2022
 · 
1 min read
Load More
AWARDS
  • NextGen Class of 2022
JOBS